Search Within

Katherine Marie Bell-McGuinn

Formats
  1. Meeting Abstract (32)
  2. Journal Article (27)
  3. Book Section (1)
Groups
  1. Gynecology Disease Management Team (35)
  2. Department of Medicine (34)
  3. Solid Tumor Oncology Division (34)
  4. GDMT, Medicine (32)
  5. Gynecologic Medicine Service (32)
  6. Surgery (9)

More Groups

People
  1. Carol Aghajanian (29)
  2. Jason Konner (13)
  3. Paul Sabbatini (11)
  4. William Tew (10)
  5. Martee Hensley (9)
  6. David Spriggs (8)

More People

Years
  1. 2021 (1)
  2. 2020 (5)
  3. 2019 (2)
  4. 2018 (4)
  5. 2017 (4)
  6. 2016 (4)

More Years

Publications
  1. Journal of Clinical Oncology (20)
  2. Gynecologic Oncology (15)
  3. Clinical Cancer Research (7)
  4. Cancer Research (5)
  5. Annals of Oncology (4)
  6. Diagnostic Pathology of Ovarian Tumors (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (20)
  2. Elsevier B.V. (15)
  3. American Association for Cancer Research (12)
  4. Oxford University Press (4)
  5. Elsevier Science, Inc. (2)
  6. Springer (2)

More Publishers

Results (60)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase I study of oral BKM120 and oral olaparib for high-grade serous ovarian cancer (HGSC) or triple-negative breast cancer (TNBC)
    Meeting Abstract

    Matulonis, U.; Wulf, G. M.; Birrer, M. J.; Westin, S. N.; Quy, P.; Bell-Mcguinn, K. M.; Lasonde, B.; Whalen, C.; Aghajanian, C.; Solit, D. B.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • VTX-2337, a TLR8 agonist, plus chemotherapy in recurrent ovarian cancer: Preclinical and phase I data by the Gynecologic Oncology Group
    Meeting Abstract

    Monk, B. J.; Brady, W. E.; Lankes, H. A.; Facciabene, A.; Manjarrez, K.; Hershberg, R. M.; Fracasso, P. M.; Bell-McGuinn, K. M.; Walker, J. L.; McCourt, C. K.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Phase I study of ABT-888 in combination with carboplatin and gemcitabine in subjects with advanced solid tumors
    Meeting Abstract

    Bell-McGuinn, K. M.; Gray, H. J.; Fleming, G. F.; Cristea, M. C.; Medina, D. M.; Xiong, H.; Dudley, M. W.; Dunbar, M.; Giranda, V. L.; Luo, Y.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Phase I study of the combination of BKM120 and olaparib for the treatment of high grade serous ovarian cancer (HGSC) and triple negative breast cancer (TNBC)
    Meeting Abstract

    Matulonis, U. A.; Wulf, G.; Cantley, L.; Mills, G.; Lasonde, B.; Atkinson, T.; Whalen, C.; Isakoff, S. J.; Westin, S.; Bell-McGuinn, K.; more...
    Cancer Research (2013)

    Fulltext@MSK | Save
  • Sorafenib or placebo with either gemcitabine or capecitabine in patients with HER-2-negative advanced breast cancer that progressed during or after bevacizumab
    Journal Article

    Schwartzberg, L. S.; Tauer, K. W.; Hermann, R. C.; Makari-Judson, G.; Isaacs, C.; Beck, J. T.; Kaklamani, V.; Stepanski, E. J.; Rugo, H. S.; Wang, W.; more...
    Clinical Cancer Research (2013)

    Fulltext@MSK | Save
  • Phase I trial of overlapping long peptides from a tumor self-antigen and poly-ICLC shows rapid induction of integrated immune response in ovarian cancer patients
    Journal Article

    Sabbatini, P.; Tsuji, T.; Ferran, L.; Ritter, E.; Sedrak, C.; Tuballes, K.; Jungbluth, A. A.; Ritter, G.; Aghajanian, C.; Bell-Mcguinn, K.; more...
    Clinical Cancer Research (2012)

    Fulltext@MSK | Save
  • Expanding radical trachelectomy for cervical cancer with tumor ≥ 2 centimeters: A report of 29 cases
    Meeting Abstract

    Wethington, S.; Sonoda, Y.; Park, K.; Bell-Mcguinn, K.; Gardner, G.; Alektiar, K.; Chi, D.; Barakat, R.; Abu Rustum, N.
    Gynecologic Oncology (2012)

    Fulltext@MSK | Save
  • Progression-free and overall survival of a modified outpatient regimen of primary intravenous/intraperitoneal paclitaxel and intraperitoneal cisplatin in ovarian, fallopian tube, and primary peritoneal cancer
    Journal Article

    Barlin, J. N.; Dao, F.; Zgheib, N. B.; Ferguson, S. E.; Sabbatini, P. J.; Hensley, M. L.; Bell-Mcguinn, K. M.; Konner, J.; Tew, W. P.; Aghajanian, C.; more...
    Gynecologic Oncology (2012)

    Fulltext@MSK | Save
  • Proceedings from the 9th International Conference on Ovarian Cancer
    Journal Article

    Schmeler, K. M.; Sood, A. K.; Bell-Mcguinn, K. M.; Coleman, R. L.; Frumovitz, M.; Sonoda, Y.; Ramirez, P. T.; Gershenson, D. M.; Barakat, R. R.; Gardner, G. J.
    Gynecologic Oncology (2012)

    Fulltext@MSK | Save
  • Phase II, open-label, randomized, multicenter study comparing the efficacy and safety of olaparib, a poly (ADP-ribose) polymerase inhibitor, and pegylated liposomal doxorubicin in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer
    Journal Article

    Kaye, S. B.; Lubinski, J.; Matulonis, U.; Ang, J. E.; Gourley, C.; Karlan, B. Y.; Amnon, A.; Bell-Mcguinn, K. M.; Chen, L. M.; Friedlander, M.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save